Working to facilitate rapid translation of scientific discoveries into therapeutics

Janina Baranowska-Kortylewicz

Janina Baranowska

Prof. Janina Baranowska-Kortylewicz, Ph.D

Dr. Janina Baranowska-Kortylewicz earned her M.Sc. from the Wrocław University of Technology (Politechnika Wrocławska) in Wrocław, Poland, and her doctorate from the University of Kentucky in Lexington, KY, USA. She continued her postgraduate research at the Albert B. Chandler Medical Center and Harvard Medical School. She is currently a professor at the University of Nebraska Medical Center. She also directs the UNMC Harry J. Bahr Radiolabeling Facility where under her supervision radioactive drugs and radioimmunoconjugates are prepared for clinical studies. The core of research activities of Dr. Baranowska-Kortylewicz’s laboratories is centered on the design, synthesis and evaluation of radioactive drugs for the targeted molecular radiotherapy and non-invasive diagnosis of cancer.

Dr. Baranowska-Kortylewicz holds several U.S. and international patents. Her bibliography can be found at Recently, the Investigational New Drug application for the clinical use of one of the radioactive drugs discovered and developed in her laboratories was approved by the FDA. Dr. Baranowska-Kortylewicz is a member of the editorial boards of several international journals and a member of national and international scientific organizations. Her expertise in the development of new radioactive drug and in the translational sciences earned her a place on several review panels.

2013-2021©European Society for Translational Medicine (EUSTM)